Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2019 | Pages:
100 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global comprehensive metabolic panel (CMP) testing market size is expected to reach USD 19 billion by 2026, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 7.3% over the forecast period. The market driven by an increasing global disease burden and the emergence of novel diagnostic products. Rising prevalence of chronic diseases coupled with increasing need to curb healthcare expenditure are expected to boost the CMP testing market by increasing the demand for early disease diagnosis and regular monitoring. Introduction of technologically advanced products, such as biochips, microarrays, and companion diagnostics, has driven the necessity for early detection of anomalies. CMP testing offers a cost-effective and time-saving method for evaluating 14 analytes for identification, diagnosis, or monitoring of several diseases. Rising consumer awareness regarding healthcare is one of the major factors anticipated to drive the market for CMP testing. Many organizations worldwide are working toward increasing awareness pertaining to diseases, available treatment options, and benefits of early diagnosis and precautions. For instance, the International Diabetes Foundation and the American Diabetes Association are some of the key organizations that emphasize the urgent need for diagnosing and monitoring diabetes through several awareness campaigns and other modes of advertisement. The buying behavior of consumers is moderately complex in the comprehensive metabolic panel testing market, due to subtle differences in product prices. The products offered by various market players have been strategically priced to increase competitive rivalry. As the market becomes increasingly competitive, consumer needs are anticipated to reach at an all-time high for improved diagnostics - in terms of safety, efficacy, sensitivity, and specificity. The medical diagnostics landscape has undergone a paradigm shift over the last few years, driven by the launch of improved diagnostic products and introduction of biomarkers. However, recurrence and disease progression remain high, especially among geriatric patients. Strong unmet needs present a key opportunity to develop breakthrough first-in-class diagnostics in the CMP testing space. Further key findings from the report suggest: • Kidney diseases accounted for the largest share of the CMP testing market in 2018 • Nearly 50% diabetics remain undiagnosed, indicating a key unmet need for CMP testing in this field • Emergence of PoC diagnostics has brought a wave of technological revolution in the clinical diagnostics landscape • Laboratories is anticipated to continue dominating the end use segment from 2019 to 2026 • Asia Pacific is positioned to witness the fastest CAGR over the forecast period
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR's internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North america
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach: Commodity flow approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 CMP Testing Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Regulatory Framework
3.5 Pricing Analysis
3.6 Market Dynamics
3.6.1 Market drivers analysis
3.6.1.1 Consumer awareness toward early diagnosis
3.6.1.2 Increasing prevalence of target diseases
3.6.1.3 Growing geriatric population base
3.6.1.4 Robust R & D
3.6.2 Market restraint analysis
3.6.2.1 Presence of ambiguous regulatory framework
3.7 CMP Testing: Market Analysis Tools
3.7.1 Industry analysis - Porter's
3.7.2 PESTLE analysis
3.8 CMP Testing: Market Analysis by Instruments, By Region, 2014 - 2026 (USD Million) (Volume, Units)
3.8.1 Piccolo Xpress
3.8.2 Skyla HB1
3.8.3 DRI-CHEM NX500i
3.8.4 Others
Chapter 4 CMP Testing Market: Segment Analysis, By Diseases, 2014 - 2026 (USD Million)
4.1 Definition and Scope
4.2 Diseases Market Share Analysis, 2018 & 2026
4.3 Segment Dashboard
4.4 Global CMP Testing Market, by Diseases, 2014 to 2026
4.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
4.5.1 Kidney disease
4.5.1.1 Kidney disease market, 2014 - 2026 (USD Million)
4.5.2 Liver disease
4.5.2.1 Liver disease market, 2014 - 2026 (USD Million)
4.5.3 Diabetes
4.5.3.1 Diabetes market, 2014 - 2026 (USD Million)
4.5.4 Others
4.5.4.1 Others market, 2014 - 2026 (USD Million)
Chapter 5 CMP Testing Market: Segment Analysis, By End Use, 2014 - 2026 (USD Million)
5.1 Definition and Scope
5.2 End Use Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global CMP Testing Market, by End Use, 2014 to 2026
5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
5.5.1 Laboratories
5.5.1.1 Laboratories market, 2014 - 2026 (USD Million)
5.5.2 PoC
5.5.2.1 PoC market, 2014 - 2026 (USD Million)
Chapter 6 CMP Testing Market: Segment Analysis, By Region, 2014 - 2026 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2018 & 2026
6.3 Regional Market Dashboard
6.4 Regional Market Snapshot
6.5 Regional Market Share and Leading Players, 2018
6.5.1 North america
6.5.2 Europe
6.5.3 Asia Pacific
6.5.4 Latin America
6.5.5 Middle East and Africa
6.6 SWOT Analysis
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 Latin America
6.6.5 Middle East and Africa
6.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2026
6.7.1 North America
6.7.1.1 North America market estimates and forecast, 2014 - 2026 (USD Million)
6.7.1.2 U.S.
6.7.1.2.1 U.S. CMP testing market, 2014 - 2026 (USD Million)
6.7.1.3 Canada
6.7.1.3.1 Canada CMP testing market, 2014 - 2026 (USD Million)
6.7.2 Europe
6.7.2.1 Europe CMP testing market, 2014 - 2026 (USD Million)
6.7.2.2 U.K.
6.7.2.2.1 U.K. CMP testing market, 2014 - 2026 (USD Million)
6.7.2.3 Germany
6.7.2.3.1 Germany CMP testing market, 2014 - 2026 (USD Million)
6.7.2.4 Spain
6.7.2.4.1 Spain CMP testing market, 2014 - 2026 (USD Million)
6.7.2.5 France
6.7.2.5.1 France CMP testing market, 2014 - 2026 (USD Million)
6.7.2.6 Italy
6.7.2.6.1 Italy CMP testing market, 2014 - 2026 (USD Million)
6.7.3 Asia Pacific
6.7.3.1 Asia Pacific CMP testing market, 2014 - 2026 (USD Million)
6.7.3.2 Japan
6.7.3.2.1 Japan CMP testing market, 2014 - 2026 (USD Million)
6.7.3.3 China
6.7.3.3.1 China CMP testing market, 2014 - 2026 (USD Million)
6.7.3.4 India
6.7.3.4.1 India CMP testing market, 2014 - 2026 (USD Million)
6.7.3.5 South Korea
6.7.3.5.1 South Korea CMP testing market, 2014 - 2026 (USD Million)
6.7.3.6 Australia
6.7.3.6.1 Australia CMP testing market, 2014 - 2026 (USD Million)
6.7.4 Latin America
6.7.4.1 Latin America CMP testing market, 2014 - 2026 (USD Million)
6.7.4.2 Brazil
6.7.4.2.1 Brazil CMP testing market, 2014 - 2026 (USD Million)
6.7.4.3 Mexico
6.7.4.3.1 Mexico CMP testing market, 2014 - 2026 (USD Million)
6.7.4.4 Argentina
6.7.4.4.1 Argentina CMP testing market, 2014 - 2026 (USD Million)
6.7.5 MEA
6.7.5.1 MEA CMP testing market, 2014 - 2026 (USD Million)
6.7.5.2 South Africa
6.7.5.2.1 South Africa CMP testing market, 2014 - 2026 (USD Million)
6.7.5.3 Saudi Arabia
6.7.5.3.1 Saudi Arabia CMP testing market, 2014 - 2026 (USD Million)
6.7.5.4 UAE
6.7.5.4.1 UAE CMP testing market, 2014 - 2026 (USD Million)
Chapter 7 CMP Testing Market - Competitive Analysis
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.1.1 Ansoff matrix
7.1.2 Heat map analysis
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 List of key distributors and channel partners
7.3.2 Key customers
7.3.3 Key company market share analysis, 2018
7.4 Public Companies
7.4.1 Company market position analysis
7.4.2 Company Market Share, by region
7.4.3 Competitive Dashboard Analysis
7.4.3.1 Market Differentiators
7.5 Private Companies
7.5.1 List of key emerging companies
7.6 Company Profiles
7.6.1 Abbott
7.6.1.1 Company overview
7.6.1.2 Financial performance
7.6.1.3 Product benchmarking
7.6.1.4 Strategic initiatives
7.6.2 Quest Diagnostics
7.6.2.1 Company overview
7.6.2.2 Financial performance
7.6.2.3 Product benchmarking
7.6.2.4 Strategic initiatives
7.6.3 Laboratory Corporation of America Holdings (LabCorp)
7.6.3.1 Company overview
7.6.3.2 Financial performance
7.6.3.3 Product benchmarking
7.6.3.4 Strategic initiatives
7.6.4 Sonic Healthcare
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.4.4 Strategic initiatives
7.6.5 UNIPATH
7.6.5.1 Company overview
7.6.5.2 Product benchmarking
7.6.6 SYNLAB International GmbH
7.6.6.1 Company overview
7.6.6.2 Product benchmarking
7.6.6.3 Strategic initiatives
List of Tables TABLE 1 List of Abbreviation TABLE 2 North America CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 3 North America CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 4 U.S. CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 5 U.S. CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 6 Canada CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 7 Canada CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 8 Europe CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 9 Europe CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 10 U.K. CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 11 U.K. CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 12 Germany CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 13 Germany CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 14 Spain CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 15 Spain CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 16 France CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 17 France CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 18 Italy CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 19 Italy CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 20 Asia Pacific CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 21 Asia Pacific CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 22 Japan CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 23 Japan CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 24 China CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 25 China CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 26 India CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 27 India CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 28 South Korea CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 29 South Korea CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 30 Australia CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 31 Australia CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 32 Latin America CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 33 Latin America CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 34 Brazil CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 35 Brazil CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 36 Mexico CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 37 Mexico CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 38 Argentina CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 39 Argentina CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 40 MEA CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 41 MEA CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 42 South Africa CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 43 South Africa CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 44 Saudi Arabia CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 45 Saudi Arabia CMP testing market, by end use, 2014 - 2026 (USD Million) TABLE 46 UAE CMP testing market, by diseases, 2014 - 2026 (USD Million) TABLE 47 UAE CMP testing market, by end use, 2014 - 2026 (USD Million)
List of Figures FIG. 1 CMP testing market segmentation FIG. 2 Market research process FIG. 3 Information procurement FIG. 4 Primary research pattern FIG. 5 Primary interviews in North America FIG. 6 Primary interviews in Europe FIG. 7 Primary interviews in Asia Pacific FIG. 8 Primary interviews in Middle East and Africa FIG. 9 Market research approaches FIG. 10 Value-chain-based sizing & forecasting FIG. 11 QFD modeling for market share assessment FIG. 12 Market formulation & validation FIG. 13 Market outlook (2018) FIG. 14 Segment Outlook (Type, 2018) FIG. 15 Strategy framework FIG. 16 Penetration & growth prospect mapping FIG. 17 User perspective analysis FIG. 18 Market driver relevance analysis (Current & future impact) FIG. 19 Current and projected prevalence of diabetes FIG. 20 Global population growth, by age-group, 2012 - 2020 (Million) FIG. 21 Market restraint relevance analysis (Current & future impact) FIG. 22 Porter's five forces analysis FIG. 23 PESTLE analysis FIG. 24 CMP testing market: Diseases movement analysis FIG. 25 Diseases segment dashboard FIG. 26 CMP testing market diseases outlook: Key takeaways FIG. 27 Kidney disease market, 2014 - 2026 (USD Million) FIG. 28 Liver disease market, 2014 - 2026 (USD Million) FIG. 29 Diabetes market, 2014 - 2026 (USD Million) FIG. 30 Others market, 2014 - 2026 (USD Million) FIG. 31 CMP testing market: End use movement analysis FIG. 32 End use segment dashboard FIG. 33 CMP testing market end use outlook: Key takeaways FIG. 34 Laboratories market, 2014 - 2026 (USD Million) FIG. 35 PoC market, 2014 - 2026 (USD Million) FIG. 36 Regional outlook, 2018 & 2026 FIG. 37 Regional market dashboard FIG. 38 Regional market place: Key takeaways FIG. 39 North America market share and key players (2018) FIG. 40 Europe market share and key players (2018) FIG. 41 Asia Pacific market share and key players (2018) FIG. 42 Latin America market share and key players (2018) FIG. 43 Middle East and Africa market share and key players (2018) FIG. 44 North America, SWOT FIG. 45 Europe, SWOT FIG. 46 Asia Pacific, SWOT FIG. 47 Latin America, SWOT FIG. 48 Middle East and Africa, SWOT FIG. 49 North America FIG. 50 North America CMP testing market, 2014 - 2026 (USD Million) FIG. 51 U.S. FIG. 52 U.S. CMP testing market, 2014 - 2026 (USD Million) FIG. 53 Canada FIG. 54 Canada CMP testing market, 2014 - 2026 (USD Million) FIG. 55 Europe FIG. 56 Europe CMP testing market, 2014 - 2026 (USD Million) FIG. 57 U.K. FIG. 58 U.K. CMP testing market, 2014 - 2026 (USD Million) FIG. 59 Germany FIG. 60 Germany CMP testing market, 2014 - 2026 (USD Million) FIG. 61 Spain FIG. 62 Spain CMP testing market, 2014 - 2026 (USD Million) FIG. 63 France FIG. 64 France CMP testing market, 2014 - 2026 (USD Million) FIG. 65 Italy FIG. 66 Italy CMP testing market, 2014 - 2026 (USD Million) FIG. 67 Asia Pacific FIG. 68 Asia Pacific CMP testing market, 2014 - 2026 (USD Million) FIG. 69 Japan FIG. 70 Japan CMP testing market, 2014 - 2026 (USD Million) FIG. 71 China FIG. 72 China CMP testing market, 2014 - 2026 (USD Million) FIG. 73 India FIG. 74 India CMP testing market, 2014 - 2026 (USD Million) FIG. 75 South Korea FIG. 76 South Korea CMP testing market, 2014 - 2026 (USD Million) FIG. 77 Australia FIG. 78 Australia CMP testing market, 2014 - 2026 (USD Million) FIG. 79 Latin America FIG. 80 Latin America CMP testing market, 2014 - 2026 (USD Million) FIG. 81 Brazil FIG. 82 Brazil CMP testing market, 2014 - 2026 (USD Million) FIG. 83 Mexico FIG. 84 Mexico CMP testing market, 2014 - 2026 (USD Million) FIG. 85 Argentina FIG. 86 Argentina CMP testing market, 2014 - 2026 (USD Million) FIG. 87 Middle East and Africa FIG. 88 MEA CMP testing market, 2014 - 2026 (USD Million) FIG. 89 South Africa FIG. 90 South Africa CMP testing market, 2014 - 2026 (USD Million) FIG. 91 Saudi Arabia FIG. 92 Saudi Arabia CMP testing market, 2014 - 2026 (USD Million) FIG. 93 UAE FIG. 94 UAE CMP testing market, 2014 - 2026 (USD Million) FIG. 95 Ansoff Matrix FIG. 96 Heat map analysis FIG. 97 Company market share analysis FIG. 98 Company market share, by region FIG. 99 Market differentiators
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
